September 11, 2014
Following a huge trend of success, Sparo Labs last week announced that they have closed a $1.25 million seed funding round. The funding for the St. Louis based startup came mostly from several angel investors in Michigan as well as a few angels in the New York and St. Louis areas.
Founders Andrew Brimer and Abigail Cohen have made it their mission to empower asthma patients with technology to better understand, track, and control their asthma. The two entrepreneurs recently took their concept to a UN summit in New York followed by a trip to Oxford to receive a Cavendish Global Health Innovation Award.
Currently there are around 30 million people in the US struggling with Asthma with roughly 1 million new patients diagnosed each year. This seed funding round will be used to continue product development and prepare for the submission and completion of the FDA approval process.
Sparo Labs has recently added two additional Washington University in St. Louis alumni full time to their team. Brimer and Cohen have certainly come a long way from their humble beginnings as a student-led project at Wash U, and I’m betting that this isn’t the last we’ll hear about them.
Did you like this article?
Get more delivered to your inbox just like it!